- Effectively treats acne vulgaris
- Provides convenient, spreadable coverage
- Penetrates easily through hair on skin or scalp
- Used once daily for 6-8 weeks
IMPORTANT SAFETY INFORMATION
Full Prescribing Information
EVOCLIN® (clindamycin phosphate) Foam, 1% is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, or a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis, including pseudomembranous colitis.
Prescribe with caution in atopic individuals.
Concomitant topical acne therapy should be used with caution since a possible cumulative irritancy may occur, especially with the use of peeling, desquamating, or abrasive agents. If irritation or dermatitis occurs, EVOCLIN Foam should be discontinued.
Diarrhea, bloody diarrhea, and pseudomembranous colitis have been reported with systemic and rarely with topical clindamycin. Discontinuation is recommended if significant diarrhea develops.
In clinical trials, the most common adverse events were headache (3%) and application-site reactions, including burning (6%), itching (1%), and dryness (1%).
The contents of EVOCLIN Foam are flammable; patients should avoid fire, flame, and/or smoking during and immediately following application.
EVOCLIN Foam is indicated for topical application in the treatment of acne vulgaris in patients 12 years and older.